ALLTRNA

Serial Number 90842409
606

Registration Progress

Application Filed
Jul 22, 2021
Under Examination
Oct 18, 2022
Approved for Publication
Jun 28, 2022
Published for Opposition
Jun 28, 2022
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Jan 24, 2026 27 days
Revival assistance for abandoned trademark

Trademark Image

ALLTRNA

Basic Information

Serial Number
90842409
Filing Date
July 22, 2021
Published for Opposition
June 28, 2022
Abandonment Date
November 24, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 24, 2025
Classes
005 042

Rights Holder

ALLTRNA, INC.

03
Address
55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Ownership History

Flagship Labs 63, Inc.

Original Applicant
03
Cambridge, MA

ALLTRNA, INC.

New Owner Before Publication #1
03
CAMBRIDGE, MA

ALLTRNA, INC.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

Next Deadline
27 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
January 24, 2026

Application History

39 events
Date Code Type Description Documents
Nov 24, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 24, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 6, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 5, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 15, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 5, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 16, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 15, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 15, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 15, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 17, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 17, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 19, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 17, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 17, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 18, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 7, 2022 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Jul 25, 2022 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jun 28, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 28, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 8, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 19, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 19, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 19, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 19, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 18, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 18, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 19, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Nucleic acid for pharmaceutical purposes; oligonucleotides for therapeutic and pharmaceutical purposes
Class 042
Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and the development of nucleic acid based and oligonucleotide pharmaceuticals

Additional Information

Pseudo Mark
ALL TRNA

Classification

International Classes
005 042